<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24937825</article-id>
      <article-id pub-id-type="pmc">4056709</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20143043</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Incontinentia pigmenti or Bloch-Sulzberger syndrome: a rare X-linked
genodermatosis<sup><xref ref-type="fn" rid="fn01">*</xref></sup>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Marques</surname>
            <given-names>Gabriela Franco</given-names>
          </name>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tonello</surname>
            <given-names>Claudio Sampieri</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sousa</surname>
            <given-names>Juliana Martins Prazeres</given-names>
          </name>
        </contrib>
        <aff> Instituto Lauro de Souza Lima (ILSL) - Bauru (SP), Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Gabriela Franco Marques, Rua Alves Guimar&#xE3;es n&#xBA;
518 apto. 136 Pinheiros, 05410-000 S&#xE3;o Paulo, SP. E-mail:
<email>gabriela_franco_@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>3</issue>
      <fpage>486</fpage>
      <lpage>489</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Incontinentia pigmenti is a rare X-linked genodermatosis that affects mainly
female neonates. The first manifestation occurs in the early neonatal period and
progresses through four stages: vesicular, verruciform, hyperpigmented and
hypopigmented. Clinical features also manifest themselves through changes in the
teeth, eyes, hair, central nervous system, bone structures, skeletal musculature
and immune system. The authors report the case of a patient with cutaneous
lesions and histological findings that are compatible with the vesicular stage,
emphasizing the importance of early diagnosis and appropriate therapeutic
management.</p>
      </abstract>
      <kwd-group>
        <kwd>Genetic diseases, X-linked</kwd>
        <kwd>Incontinentia pigmenti</kwd>
        <kwd>Pigmentation disorders</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Incontinentia pigmenti or Bloch-Sulzberger syndrome is a rare genodermatosis, linked
to X chromosome, of autosomal dominant character, which affects ectodermal and
mesodermal tissues, such as skin, eyes, teeth and central nervous system.<sup><xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r04" ref-type="bibr">4</xref></sup> There are around 800 registered cases worldwide and the
estimated incidence is about 1 to every 40.000 children.<sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>It is a disease of difficult diagnosis, which manifests itself during the first
months of life and affects mainly female neonates, being lethal, in most cases, when
it occurs in males.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> It was
described for the first time by Garrod in 1903, and Sulzberger was the one who
recognized the pathogenesis involved in the syndrome, in 1926.<sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>The authors report a case of typical clinical manifestations and histopathological
findings compatible with incontinentia pigmenti in the vesicularbullous stage,
emphasizing the importance of recognizing this disease due to great possibility of
extracutaneous manifestations, which must be treated early to avoid sequelae.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Female patient, one month-old, with onset of small papules, vesicles and linear
crusts on upper and lower limbs since birth. Prenatal and delivery occurred without
complications and the child did not present comorbidities.</p>
      <p>During the dermatological exam vesiculobullous injuries and crusts were found in a
linear disposition along the lines of Blaschko, grouped, located on flexural
surfaces of the upper limbs, lateral face of the right lower limb and posterior face
of the left lower limb (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p><bold>A)</bold> Vesicular- Bullous linear lesions of flexural surfaces of
upper limbs <bold>B)</bold> Vesicular- Bullous lesions and crusts on lateral
side of lower right limb</p>
        </caption>
        <graphic xlink:href="abd-89-03-0486-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p><bold>A)</bold> Vesicular-Bullous lesions on posterior face of lower left
limb <bold>B)</bold> Lesions on lateral face of lower right limb</p>
        </caption>
        <graphic xlink:href="abd-89-03-0486-g02"/>
      </fig>
      <p>The anatomopathological exam revealed spongiosis and intraepidermal vesicles
containing numerous eosinophils (<xref ref-type="fig" rid="f03">Figures 3</xref>,
<xref ref-type="fig" rid="f04">4</xref> and <xref ref-type="fig" rid="f05">5</xref>). The Tzanck test identified no viral inclusions or bacterial
colonies.</p>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Anatomopathological exam: Intraepidermal vesicles (H&amp;E, 40x)</p>
        </caption>
        <graphic xlink:href="abd-89-03-0486-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Anatomopathological exam: Spongiosis and numerous eosinophils inside of the
intraepidermal vesicle (H&amp;E, 100x)</p>
        </caption>
        <graphic xlink:href="abd-89-03-0486-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Anatomopathological exam: In the detail, eosinophils inside of intraepidermal
vesicle (H&amp;E, 200x)</p>
        </caption>
        <graphic xlink:href="abd-89-03-0486-g05"/>
      </fig>
      <p>Physical exam findings and the result of complementary exams were compatible with the
diagnosis of Bloch-Sulzberger syndrome in the vesicular-bullous stage. The cutaneous
lesions were treated with low-potency topical corticoid and emollients; the child
was referred to neurological, ophthalmological and pediatric evaluation, which were
within normal standards. Relatives were oriented regarding the evolution phases of
the disease and the need of multidisciplinary follow-up.</p>
      <p>After six months there was an onset of linear hypochromic lesions on the locations
previously affected by vesiculobullous lesions, corresponding to the
hypopigmentation stage of Bloch-Sulzberger syndrome (<xref ref-type="fig" rid="f06">Figure 6</xref>).</p>
      <fig id="f06" orientation="portrait" position="float">
        <label>FIGURE 6</label>
        <caption>
          <p><bold>A)</bold> Absence of lesions on upper limbs <bold>B)</bold> Residual
linear hypochromic lesions on posterior face of left lower limb
<bold>C)</bold> Linear hypochromic lesions on posterior face of right
lower limb</p>
        </caption>
        <graphic xlink:href="abd-89-03-0486-g06"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Incontinentia pigmenti is caused by a mutation on the NEMO gene, located on the q28
portion of X chromosome. It affects the skin and several systemic organs with
variable clinical expression.<sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>The first manifestations occur in the neonatal period and progress through several
well-defined steps, possibly occurring concomitantly or sequentially. The first
stage is named vesicular or vesicular-bullous, characterized by vesicles and linear
inflammatory bubbles that appear at birth or during the first two months and can
last from weeks to months. The second stage is the verrucous, when linear verrucous
hyperkeratotic plaques appear with variable duration. Next the hyperpigmentation
stage occurs, with the onset of brown or bluish-gray pigmentation, distributed in
Blaschko lines, starting in infancy and slowly fading until it disappears in
adulthood. The last stage is the hypopigmentation, when linear hypopigmented macules
appear, with absence of cutaneous appendixes on trunk and limbs during adult
age.<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r07" ref-type="bibr">7</xref></sup></p>
      <p>In the case reported, there was the predominance of vesiculobullous lesions, which
allowed the clinical picture classification as vesicular-bullous stage. However,
some lesions presented with a verrucous aspect and the onset of crusts, suggesting
the start of the second stage of the disease, corresponding to the verrucous
stage.</p>
      <p>In up to 80% of the cases of incontinentia pigmenti there are associated
extracutaneous manifestations.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup> The following structures may be affected: teeth, manifesting as
anodontia, delayed dentition and malformed teeth; retinal and corneal,
microphthalmia, cataract, iris hypoplasia, uveitis, nystagmus, strabismus and myopia
changes indicate ocular involvement; baldness may represent hair involvement;
central nervous system involvement may have variable clinical presentation with
convulsions, seizures, mental retardation, ischemic strokes, hydrocephalus and
anatomical abnormalities; bone structures and skeletal musculature may have their
development compromised and the child evolves with syndactyly, cranial deformities,
dwarfism, supernumerary ribs, hemiatrophy and shortening the legs and arms.
<sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r09" ref-type="bibr">9</xref></sup> There may be immunological changes due to defective
neutrophil chemotaxis and lymphocyte function. Since it is a genodermatosis, there
is also the possibility of association with malignancies, such as hematological
neoplasms, Wilms' tumor and retinoblastoma.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>The patient in question underwent multidisciplinary evaluation by a team composed of
pediatricians, neurologists and ophthalmologists and up to now no extracutaneous
manifestation was identified. It is known, however, that extracutaneous involvement
may appear late, which justifies the continuous follow-up of these patients even
after the vesicularbullous lesions have disappeared.</p>
      <p>Histopathology varies according to the evolutionary stage of the disease. In the
first stages it shows an increase of eosinophils and formation of intraepidermal
vesicules. In the verrucous phase hyperkeratosis, dyskeratosis, acanthosis and
papillomatosis can be identified. Later, melanine deposits on the dermis with
melanophages are found in the hyperpigmentation stage. Finally, in the
hypopigmentation stage discreet epidermal atrophy and absence of annexes may be
seen.<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Histopathological findings associated with physical characteristics are enough to
define the diagnosis. Recently diagnostic criteria were proposed for the syndrome,
the major criterium being the typical cutaneous alterations of one of the
evolutionary phases of the disease. The minor criteria correspond to dental, ocular,
neurological, osseous and immunological alterations, as well as compatible
anatomopathological exam. Genetic alteration and presence of family members also
affected by the disease should also be taken into consideration.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>The cutaneous manifestations do not need specific treatment; spontaneous resolution
of lesions occurs normally. Emollients and topical corticoids can be used in the
first stages of the disease. Secondary bacterial infections may occur and must be
treated with antibiotics. The management of extracutaneous manifestations must be
done by a multidisciplinary team and varies according to the affected organ.
Furthermore, genetic counseling is also important since the disorder is of autosomal
dominant transmission.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>Therefore, in spite of the rarity of this pathology, one must be alert for early
diagnosis, recognizing the typical cutaneous manifestations of each evolutionary
phase of the disease, for adequate genetic counseling and better management of
extracutaneous manifestations when these are present.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interests: none</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial Support: none</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Work performed at Instituto Lauro de Souza Lima (ILSL) - Bauru (SP), Brazil.</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Borges J, Cuzzi T, Mandarim-de-Lacerda CA,
Manela-Azulay M. Incontinentia pigmenti or Bloch-Sulzberger syndrome: a rare
X-linked genodermatosis. An Bras Dermatol. 2014;89(3):486-9.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M&#xFC;hlenst&#xE4;dt</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eigelshoven</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hoff</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Reifenberger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Homey</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bruch-Gerharz</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Bloch-Sulzberger syndrome</article-title>
          <source>Hautarzt</source>
          <year>2010</year>
          <volume>61</volume>
          <fpage>831</fpage>
          <lpage>833</lpage>
          <pub-id pub-id-type="pmid">20865235</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ehrenreich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tarlow</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Godlewska-Janusz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic
disorder</article-title>
          <source>Cutis</source>
          <year>2007</year>
          <volume>79</volume>
          <fpage>355</fpage>
          <lpage>362</lpage>
          <pub-id pub-id-type="pmid">17569396</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motamedi</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Lotfi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Azizi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Moshref</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Farhadi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Incontinentia pigmenti</article-title>
          <source>Indian J Pathol Microbiol</source>
          <year>2010</year>
          <volume>53</volume>
          <fpage>302</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">20551538</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>MAC</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>LAF</given-names>
            </name>
            <name>
              <surname>Budel</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Cabral</surname>
              <given-names>CSP</given-names>
            </name>
            <name>
              <surname>Feltrim</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>X-linked incontinentia pigmenti or Bloch-Sulzberger syndrome: a
case report</article-title>
          <source>An Bras Dermatol</source>
          <year>2010</year>
          <volume>85</volume>
          <fpage>372</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="pmid">20676473</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buinauskiene</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Buinauskaite</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Valiukeviciene</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Incontinentia pigmenti (Bloch-Sulzberger syndrome) in
neonates</article-title>
          <source>Medicina (Kaunas)</source>
          <year>2005</year>
          <volume>41</volume>
          <fpage>496</fpage>
          <lpage>499</lpage>
          <pub-id pub-id-type="pmid">15998988</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Incontinentia pigmenti in a newborn with NEMO
mutation</article-title>
          <source>J Korean Med Sci</source>
          <year>2011</year>
          <volume>26</volume>
          <fpage>308</fpage>
          <lpage>311</lpage>
          <pub-id pub-id-type="pmid">21286028</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Llano-Rivas</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Soler-S&#xE1;nchez</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>M&#xE1;laga-Di&#xE9;guez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez-Toral</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Incontinentia pigmenti. Four patients with different clinical
manifestations</article-title>
          <source>An Pediatr (Barc)</source>
          <year>2012</year>
          <volume>76</volume>
          <fpage>156</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">22036144</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Trpinac</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gencik</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Obradovic</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Dental and oral anomalies in incontinentia pigmenti: a systematic
review</article-title>
          <source>Clin Oral Investig</source>
          <year>2013</year>
          <volume>17</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Trpinac</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Obradovic</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Systematic review of central nervous system anomalies in
incontinentia pigmenti</article-title>
          <source>Orphanet J Rare Dis</source>
          <year>2013</year>
          <volume>8</volume>
          <fpage>25</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">23406512</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mini&#x107;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Trpinac</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Obradovi&#x107;</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Incontinentia pigmenti: diagnostic criteria
update</article-title>
          <source>Clin Genet</source>
          <day>26</day>
          <month>6</month>
          <year>2013</year>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
